Drug Research

Researchers at Chalmers University of Technology in Sweden have created synthetic DNA that directs the cellular creation of proteins with the aid of an AI. With the help of technology, vaccines, medications for serious illnesses, and alternative dietary proteins...

There is a new medicine that has surpassed Bluebird Bio as the costliest in the world. Hemgenix, a haemophilia B gene therapy developed by CSL Behring and uniQure, debuted as the first gene therapy authorised for the uncommon illness following...

To support innovative approaches for the development, manufacture, and quality control (QC) of medicines, along with new technologies, digitalization, novel materials, and novel devices for patients in the European Union, the European Medicines Agency (EMA) formed the Quality Innovation...

RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore, and the Agency for Science, Technology and Research (A*STAR) announced the signing of a master research collaboration agreement...

Merck, a leading science and technology company, invests more than € 290 million in its biosafety testing capacity at Rockville, Maryland, USA. This will significantly increase the company’s ability to conduct biosafety testing and analytical development services. Biosafety testing...

The Antimicrobial Resistance Multi-Stakeholder Partnership Platform was launched to ensure the growing threats and impacts of antimicrobial resistance are addressed globally. The Food and Agriculture Organization of the United Nations (FAO), the UN Environment Programme (UNEP), the World Health Organization...

Regeneron Pharmaceuticals, Inc.  and CytomX Therapeutics, Inc.  announced a collaboration and licensing agreement to create conditionally-activated investigational bispecific cancer therapies utilizing CytomX's Probody® therapeutic platform and Regeneron's Veloci-Bi® bispecific antibody development platform. The collaboration is strategically focused on applying CytomX's...